Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated TCM and Western Medicine for Gastrointestinal Recovery After Hepatectomy
ChiCTR-IIR-17011434Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jul 2017
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of simotang and thiamine in hepatocellular carcinoma (HCC), Cirrhosis and Postoperative gastrointestinal dysfunction (POGD), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Time to recovery of bowel sounds, Time to anal exhaust and 1 more. Started Jul 2017; status: recruiting.
02
Drugs
simotangthiamine
03
Conditions
hepatocellular carcinoma (HCC)CirrhosisPostoperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on ChiCTR-IIR-17011434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17011434.